Neuland Laboratories share news, announcements and annual reports
NSE: NEULANDLABBSE: 524558Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹19,280.00.
30 Oct: open ₹19,345.00, high ₹19,920.00, low ₹19,025.00
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹25,275 Cr356th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 50.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 13.48
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.17%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 29.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 32.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.10
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 60,08043.6% delivered
Neuland Laboratories analyst meets
134 filed, newest first. Page 2 of 3.
Jul 2023
28 Jul · Analysts
Jun 2023
13 Jun · Analysts
May 2023
29 May · Analysts
4 May · Analysts
Feb 2023
2 Feb · Analysts
Oct 2022
28 Oct · Analysts
28 Oct · Analysts
Jul 2022
27 Jul · Analysts
Jun 2022
Jan 2022
28 Jan · Analysts
Dec 2021
10 Dec · Analysts
Nov 2021
16 Nov · Analysts
Oct 2021
Aug 2021
27 Aug · Analysts
20 Aug · Analysts
12 Aug · Analysts
Jul 2021
29 Jul · Analysts
Jun 2021
24 Jun · Analysts
11 Jun · Analysts
9 Jun · Analysts
1 Jun · Analysts
May 2021
25 May · Analysts
21 May · Analysts
8 May · Analysts
Mar 2021
30 Mar · Analysts
26 Mar · Analysts
4 Mar · Analysts
Feb 2021
26 Feb · Analysts
23 Feb · Analysts
16 Feb · Analysts
Jan 2021
27 Jan · Analysts
Dec 2020
31 Dec · Analysts
Nov 2020
26 Nov · Analysts
18 Nov · Analysts
Oct 2020
26 Oct · Analysts
Sep 2020
10 Sep · Analysts
8 Sep · Analysts
Aug 2020
27 Aug · Analysts
20 Aug · Analysts
Jul 2020
31 Jul · Analysts
May 2020
Mar 2020
19 Mar · Analysts
Jan 2020
24 Jan · Analysts
Dec 2019
5 Dec · Analysts
Nov 2019
7 Nov · Analysts
Aug 2019
23 Aug · Analysts
8 Aug · Analysts
Jul 2019
5 Jul · Analysts
4 Jul · Analysts
Jun 2019
13 Jun · Analysts